Saturday, July 2, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

DeNovix to give away Platinum Edition CellDrop™ Automated Cell Counter in celebration of prestigious award

by Medical Finance
in News
DeNovix to give away Platinum Edition CellDrop™ Automated Cell Counter in celebration of prestigious award
9
SHARES
100
VIEWS
Share on FacebookShare on Twitter

DeNovix Inc. is giving away a Platinum Edition CellDrop™ Automated Cell Counter to celebrate the instrument’s newly awarded Platinum Seal of Quality from SelectScience.

DeNovix to give away Platinum Edition CellDrop™ Automated Cell Counter in celebration of prestigious award

Image Credit: DeNovix Inc.

Researchers around the world can register for free for a chance to win the Platinum Edition CellDrop at: denovix.com/platinum.

Participants can earn additional chances to win by completing easy actions, such as sharing with friends and colleagues, engaging with the DeNovix social media accounts and more. The contest will close on April 29th at 11:59 PM (EST), and the winner will be randomly selected and notified the following week.

The Seal of Quality program recognizes life science products that have consistently received the highest ratings in categories such as ease of use, service and value. The CellDrop follows the DS-11 Series Spectrophotometer / Fluorometer in achieving this top award, making DeNovix the first company to receive a second Platinum Seal of Quality for life science instrumentation.

About CellDrop Cell Counters

The CellDrop Automated Cell Counter is a dual fluorescence and brightfield instrument that features DirectPipette™ technology. This unique sample loading method eliminates the need for disposable slides, therefore reducing the plastic waste and ongoing costs associated with routine cell counting.

Systems include a high definition 7 inch touchscreen for live preview and instant review of results. Pre-installed EasyApps™ software includes applications for AO/PI, Brightfield, Trypan Blue, GFP and user customized methods. The software delivers rapid cell counts, viability reports and transfection efficiency assays. All instruments feature Wi-Fi, USB and Ethernet connectivity, allowing users to easily export data via email, network drives, network printers or USB drive. CellDrop Automated Cell Counters are available in dual fluorescence and brightfield or brightfield only models.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

UCLA study provides new insights into molecular ‘crosstalk’ in pancreas cancer cells

New therapy makes immunologically ‘cold’ tumors hot enough for immune attack

by Medical Finance
July 2, 2022
0

Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein...

New approach using RNA therapeutic can fix protein problems in cystic fibrosis

Scientists develop first drug to treat uncontrolled secretion of mucins in the airways

by Medical Finance
July 2, 2022
0

A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat...

Study hints a potential difference in molecular clockworks between the master and slave clock neurons

Study highlights the cascading ecosystem consequences of sublethal parasitic infections in wild animals

by Medical Finance
July 2, 2022
0

Deer, caribou, bison and other similar animals are often infected by a range of internal parasites, including worms called helminths....

Study: Human Galectin-9 Potently Enhances SARS-CoV-2 Replication and Inflammation In Airway Epithelial Cells. Image Credit: Corona Borealis Studio / Shutterstock.com

Researchers investigate Galectin-9 as a new treatment target for COVID-19

by Medical Finance
July 2, 2022
0

Most early treatments against the coronavirus disease 2019 (COVID-19) have targeted the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...

Study: Whole-genome risk prediction of common diseases in human preimplantation embryos. Image Credit: Explode / Shutterstock.com

Predicting the risk of some common diseases in preimplantation fertilized embryos

by Medical Finance
July 2, 2022
0

In vitro fertilized embryos are genetically tested before implantation to reduce the transmission of common diseases that can be inherited...

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

Study determines how genetics and environmental conditions interact during plant development

by Medical Finance
July 2, 2022
0

Iowa State University scientists have harnessed data analytics to look "under the hood" of the mechanisms that determine how genetics...

Next Post
Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

Scientists discover antibody that inhibits a broad range of sarbecoviruses

Some states still pushing ineffective covid antibody treatments

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: A Miniaturized Electrostatic Precipitator Respirator Effectively Removes Ambient SARS-CoV-2 Bioaerosols. Image Credit: NARONG JHANWATTANA/Shutterstock
    Efficacy of miniaturized electrostatic precipitator respirators in removal of SARS-CoV-2 bioaerosols compared to N95 masks
  • Artificially Colored MRI Scan Of Human Brain Daisy Daisy a8c5d8bbbf824bc8932308e30187510f 620x480
    Research uncovers how a mouse brain understands sensory information
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply